Haleon (NYSE:HLN) Raised to “Strong-Buy” at Argus

Haleon (NYSE:HLN) was upgraded by analysts at Argus to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.

Other equities analysts also recently issued research reports about the stock. HSBC raised shares of Haleon from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, January 21st. Jefferies Financial Group reiterated a “buy” rating on shares of Haleon in a report on Tuesday, January 20th. Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research note on Thursday, January 22nd. Finally, Deutsche Bank Aktiengesellschaft downgraded Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $12.33.

Haleon Trading Down 2.8%

Shares of HLN stock opened at $10.31 on Tuesday. The stock has a market cap of $45.90 billion, a price-to-earnings ratio of 26.42 and a beta of 0.18. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 0.47. Haleon has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The firm’s 50 day moving average price is $10.52 and its two-hundred day moving average price is $9.87.

Hedge Funds Weigh In On Haleon

A number of institutional investors have recently added to or reduced their stakes in HLN. SOA Wealth Advisors LLC. grew its stake in shares of Haleon by 60.5% during the third quarter. SOA Wealth Advisors LLC. now owns 3,105 shares of the company’s stock valued at $28,000 after acquiring an additional 1,170 shares in the last quarter. Citizens National Bank Trust Department lifted its stake in shares of Haleon by 167.4% in the third quarter. Citizens National Bank Trust Department now owns 3,276 shares of the company’s stock worth $29,000 after acquiring an additional 2,051 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in shares of Haleon by 101.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after acquiring an additional 1,433 shares in the last quarter. Atlantic Union Bankshares Corp boosted its holdings in Haleon by 293.7% in the third quarter. Atlantic Union Bankshares Corp now owns 3,697 shares of the company’s stock valued at $33,000 after purchasing an additional 2,758 shares during the last quarter. Finally, Stance Capital LLC acquired a new stake in Haleon during the 3rd quarter valued at approximately $34,000. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.